ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 48 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,172,993 | -66.2% | 3,161,707 | -54.5% | 0.02% | -65.2% |
Q3 2022 | $3,475,000 | -14.4% | 6,949,416 | 0.0% | 0.07% | -17.9% |
Q2 2022 | $4,060,000 | -17.9% | 6,949,416 | 0.0% | 0.08% | -24.3% |
Q1 2022 | $4,948,000 | -46.1% | 6,949,416 | 0.0% | 0.11% | -42.2% |
Q4 2021 | $9,173,000 | -42.6% | 6,949,416 | 0.0% | 0.19% | -38.5% |
Q3 2021 | $15,984,000 | -47.6% | 6,949,416 | 0.0% | 0.31% | -42.4% |
Q2 2021 | $30,508,000 | -39.5% | 6,949,416 | 0.0% | 0.54% | -48.9% |
Q1 2021 | $50,453,000 | +68.1% | 6,949,416 | 0.0% | 1.06% | +78.8% |
Q4 2020 | $30,021,000 | +5.1% | 6,949,416 | 0.0% | 0.59% | -14.7% |
Q3 2020 | $28,562,000 | -34.4% | 6,949,416 | -4.3% | 0.70% | -45.2% |
Q2 2020 | $43,560,000 | -34.7% | 7,259,988 | -18.1% | 1.27% | -40.1% |
Q1 2020 | $66,733,000 | -45.2% | 8,862,247 | 0.0% | 2.12% | -45.5% |
Q4 2019 | $121,856,000 | +14.9% | 8,862,247 | -0.7% | 3.89% | -10.0% |
Q3 2019 | $106,012,000 | -15.1% | 8,923,600 | 0.0% | 4.32% | -3.6% |
Q2 2019 | $124,841,000 | -13.0% | 8,923,600 | +11.2% | 4.48% | -18.5% |
Q1 2019 | $143,462,000 | +13.7% | 8,023,600 | 0.0% | 5.50% | +8.9% |
Q4 2018 | $126,211,000 | – | 8,023,600 | – | 5.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 5,307,751 | $3,101,000 | 1.18% |
TANG CAPITAL MANAGEMENT LLC | 2,000,000 | $1,168,000 | 0.18% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $4,060,000 | 0.08% |
Artal Group S.A. | 1,803,858 | $1,054,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 616,402 | $360,000 | 0.05% |
RA Capital Management | 3,040,885 | $1,776,000 | 0.05% |
Forefront Analytics, LLC | 92,641 | $58,000 | 0.03% |
Temasek Holdings (Private) Ltd | 4,319,049 | $2,523,188 | 0.01% |
FEDERATED HERMES, INC. | 8,309,859 | $4,853,000 | 0.01% |
Cormorant Asset Management, LP | 256,649 | $150,000 | 0.01% |